<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00967421</url>
  </required_header>
  <id_info>
    <org_study_id>ES437291 VALIDAD</org_study_id>
    <nct_id>NCT00967421</nct_id>
  </id_info>
  <brief_title>Development of a Valid Test Battery for Assessing Driving Ability When Influenced by Drugs.</brief_title>
  <acronym>VALIDAD</acronym>
  <official_title>Development of a Valid Test Battery for Assessing Driving Ability When Influenced by Drugs.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Olavs Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>SINTEF Health Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Norwegian University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Norwegian Institute of Public Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>St. Olavs Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the validation study is to develop a valid test battery for assessing driving
      ability in a driving simulator when influenced by drugs. Ethanol has known, well-documented
      and well-characterized effects on driving behaviour and accident risk, and will be used to
      assess the simulator test scenarios' sensitivity to drug effects. Once the test scenarios
      have been refined and their ability to predict driving accident risk have been validated, we
      plan to use the simulator to assess driving ability under the influence of different drugs
      suspected to produce driving impairment.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 2009</start_date>
  <completion_date type="Actual">November 2010</completion_date>
  <primary_completion_date type="Actual">November 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Standard deviation of lateral position on road (SDLP)</measure>
    <time_frame>Instantly (while the subject is inebriated)</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Automobile Driving</condition>
  <arm_group>
    <arm_group_label>BAC 0.5</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>BAC level 0.5 g/dL (drink + placebo pill)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BAC 1.0</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>BAC level 1.0 g/dL (drink + placebo pill)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>BAC level 0,0 g/dL (placebo drink+ placebo pill)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ethanol</intervention_name>
    <description>BAC level 0.5 g/dL (drink + placebo pill). Drink with 2,4 grams per kilo body weight, administered orally during 60 min, administration ending 30 min prior to start of testing. Placebo pill.</description>
    <arm_group_label>BAC 0.5</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ethanol</intervention_name>
    <description>BAC level 1.0 g/dL (drink + placebo pill). Drink with 3,6 grams per kilo body weight, administered orally during 60 min, administration ending 30 min prior to start of testing. Placebo pill.</description>
    <arm_group_label>BAC 1.0</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo drink</intervention_name>
    <description>Placebo drink containing no alcohol + placebo pill</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy, caucasian males aged 25-50 years in possession of a valid driver's license
             for the last 5 years.

          -  Recreational alcohol drinkers without alcohol dependence or abuse, no traffic-related
             convictions or alcohol-influenced behavioural disturbances.

          -  1 or 0 points on the modified Apfel scale for predicting post-operative
             nausea/vomiting (non-smoker, previously experienced nausea/vomiting post-operatively,
             previously experienced motion sickness)

        Exclusion Criteria:

          -  Females (risk of teratogenicity)

          -  Non-caucasian ethnicity (possibility of deviant ethanol metabolism)

          -  Previous strong reactions such as nausea, fainting etc. during blood sampling

          -  Previous abnormal reactions to ethanol

          -  Previous convictions related to drug intoxication

          -  Previous excessive drug use

          -  Regular use of prescription drugs

          -  Two points or more according to the modified Apfel criteria
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lars Slørdal, PhD, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Norwegian University of Science and Technology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gunnar D Jenssen</last_name>
    <role>Principal Investigator</role>
    <affiliation>SINTEF Health Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>SINTEF Health and Research</name>
      <address>
        <city>Trondheim</city>
        <zip>7465</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <results_reference>
    <citation>Helland A, Jenssen GD, Lervåg LE, Westin AA, Moen T, Sakshaug K, Lydersen S, Mørland J, Slørdal L. Comparison of driving simulator performance with real driving after alcohol intake: a randomised, single blind, placebo-controlled, cross-over trial. Accid Anal Prev. 2013 Apr;53:9-16. doi: 10.1016/j.aap.2012.12.042. Epub 2013 Jan 28.</citation>
    <PMID>23357031</PMID>
  </results_reference>
  <results_reference>
    <citation>Helland A, Jenssen GD, Lervåg LE, Moen T, Engen T, Lydersen S, Mørland J, Slørdal L. Evaluation of measures of impairment in real and simulated driving: Results from a randomized, placebo-controlled study. Traffic Inj Prev. 2016;17(3):245-50. doi: 10.1080/15389588.2015.1065975. Epub 2015 Jul 6.</citation>
    <PMID>26147898</PMID>
  </results_reference>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 26, 2009</study_first_submitted>
  <study_first_submitted_qc>August 26, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 27, 2009</study_first_posted>
  <last_update_submitted>September 28, 2017</last_update_submitted>
  <last_update_submitted_qc>September 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 2, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Driving</keyword>
  <keyword>DUI</keyword>
  <keyword>Driving simulation</keyword>
  <keyword>Drugs</keyword>
  <keyword>Ethanol</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ethanol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

